Currently, there are 455.34M common shares owned by the public and among those 424.46M shares have been available to trade.
The company’s stock has a 5-day price change of 2.26% and -7.07% over the past three months. GEHC shares are trading 6.89% year to date (YTD), with the 12-month market performance up to 6.14% higher. It has a 12-month low price of $62.35 and touched a high of $94.50 over the same period. GEHC has an average intraday trading volume of 2.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.94%, 4.82%, and 5.01% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of GE HealthCare Technologies Inc (NASDAQ: GEHC) shares accounts for 75.03% of the company’s 455.34M shares outstanding.
It has a market capitalization of $37.73B and a beta (3y monthly) value of 1.36. The stock’s trailing 12-month PE ratio is 24.12, while the earnings-per-share (ttm) stands at $3.43. The company has a PEG of 2.10 and a Quick Ratio of 0.79 with the debt-to-equity ratio at 1.31. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.46% over the week and 2.04% over the month.
Earnings per share for the fiscal year are expected to increase by 8.67%, and 11.53% over the next financial year. EPS should grow at an annualized rate of 11.50% over the next five years, compared to -2.54% over the past 5-year period.
Looking at the support for the GEHC, a number of firms have released research notes about the stock. Goldman stated their Neutral rating for the stock in a research note on May 30, 2024, with the firm’s price target at $87. HSBC Securities coverage for the GE HealthCare Technologies Inc (GEHC) stock in a research note released on February 15, 2024 offered a Buy rating with a price target of $100. UBS was of a view on February 12, 2024 that the stock is Neutral, while Jefferies gave the stock Hold rating on November 30, 2023, issuing a price target of $80. UBS on their part issued Sell rating on November 27, 2023.
